Similarly, CXCR1/CXCR2 inhibition with the small molecule inhibitor ladarixin diminished the presence G-MDSCs near EY epithelia basement membranes and decreased carcinoma incidence and burden in EY mice (Fig. 5j and Supplementary Fig. 8g). Here, CXCR2 is linked to carcinoma.